$APVO
Aptevo Therapeutics Inc.

2021 Q1 Form 10-K Financial Statement

#000156459021016875 Filed on March 31, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q4 2020
Revenue $2.421M $2.370M $4.309M
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.950M $4.280M $13.95M
YoY Change 9.12% 21.25% -44.94%
% of Gross Profit
Research & Development $5.360M $4.910M $17.85M
YoY Change 33.67% 11.34% -27.91%
% of Gross Profit
Depreciation & Amortization $294.0K $350.0K $1.406M
YoY Change -36.09% -35.19% -37.09%
% of Gross Profit
Operating Expenses $9.310M $9.190M $17.85M
YoY Change 22.15% 15.74% -64.37%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$780.0K -$350.0K -$1.330M
YoY Change 183.64% -23.91% -36.67%
Pretax Income -$7.670M -$7.170M -$30.92M
YoY Change -23.3% -14.64% -28.19%
Income Tax
% Of Pretax Income
Net Earnings -$7.256M -$7.050M -$17.75M
YoY Change -350.47% -13.71% -56.12%
Net Earnings / Revenue -299.71% -297.47% -411.93%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.643M -$1.826M -$5.236M
COMMON SHARES
Basic Shares Outstanding 4.449M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $57.50M $40.00M $40.00M
YoY Change 367.48% 222.58% 222.58%
Cash & Equivalents $58.78M $39.98M $40.00M
Short-Term Investments
Other Short-Term Assets $2.900M $133.0K $4.900M
YoY Change 136.93% -16.88% 11.36%
Inventory
Prepaid Expenses $2.228M
Receivables $2.400M $2.400M $2.400M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $62.90M $47.26M $47.30M
YoY Change 324.28% 57.57% 57.67%
LONG-TERM ASSETS
Property, Plant & Equipment $2.712M $2.815M $5.500M
YoY Change -61.8% -28.66% -28.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $746.0K $746.0K $700.0K
YoY Change -77.39% -1.45% -93.81%
Total Long-Term Assets $5.853M $6.283M $6.200M
YoY Change -43.59% -73.16% -73.5%
TOTAL ASSETS
Total Short-Term Assets $62.90M $47.26M $47.30M
Total Long-Term Assets $5.853M $6.283M $6.200M
Total Assets $68.75M $53.55M $53.50M
YoY Change 172.83% 0.26% 0.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.400M $5.600M $5.600M
YoY Change 8.0% -56.92% -56.92%
Accrued Expenses $1.100M $3.700M $3.700M
YoY Change -35.29% -17.78% -17.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $10.17M $5.000M $5.000M
YoY Change -74.83% -74.87%
Total Short-Term Liabilities $29.30M $14.54M $14.50M
YoY Change 318.99% -61.98% -62.04%
LONG-TERM LIABILITIES
Long-Term Debt $4.600M $20.10M $20.10M
YoY Change
Other Long-Term Liabilities $24.30M $2.400M $2.400M
YoY Change 683.87% -27.27% -27.27%
Total Long-Term Liabilities $28.90M $22.50M $22.50M
YoY Change 832.26% 581.82% 581.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.30M $14.54M $14.50M
Total Long-Term Liabilities $28.90M $22.50M $22.50M
Total Liabilities $58.25M $36.95M $37.00M
YoY Change 476.72% -11.1% -11.06%
SHAREHOLDERS EQUITY
Retained Earnings -$192.9M -$185.6M
YoY Change 10.57%
Common Stock $203.4M $202.2M
YoY Change 12.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.50M $16.59M $16.60M
YoY Change
Total Liabilities & Shareholders Equity $68.75M $53.55M $53.50M
YoY Change 172.83% 0.26% 0.19%

Cashflow Statement

Concept 2021 Q1 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$7.256M -$7.050M -$17.75M
YoY Change -350.47% -13.71% -56.12%
Depreciation, Depletion And Amortization $294.0K $350.0K $1.406M
YoY Change -36.09% -35.19% -37.09%
Cash From Operating Activities -$7.504M -$6.120M -$29.32M
YoY Change -32.85% 20.0% -30.83%
INVESTING ACTIVITIES
Capital Expenditures $191.0K -$90.00K $88.00K
YoY Change -42.48%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $28.12M
YoY Change -100.0% 561.65%
Cash From Investing Activities -$191.0K -$90.00K $28.03M
YoY Change -100.68% 584.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $5.000M $22.10M
YoY Change -77.38%
Cash From Financing Activities 23.94M 21.24M 23.87M
YoY Change -208.32% -16438.46% 18.49%
NET CHANGE
Cash From Operating Activities -7.504M -6.120M -29.32M
Cash From Investing Activities -191.0K -90.00K 28.03M
Cash From Financing Activities 23.94M 21.24M 23.87M
Net Change In Cash 16.25M 15.03M 22.59M
YoY Change -414.93% -387.38% -224.54%
FREE CASH FLOW
Cash From Operating Activities -$7.504M -$6.120M -$29.32M
Capital Expenditures $191.0K -$90.00K $88.00K
Free Cash Flow -$7.695M -$6.030M -$29.41M
YoY Change -31.14% 18.24% -30.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
us-gaap:RoyaltyMember
CY2019 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
us-gaap:RoyaltyMember
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1078000
CY2020 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39979000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
133000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
160000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
47264000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
29995000
CY2019Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
7498000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3946000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
2555000
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4449422
CY2020Q2 dei Entity Public Float
EntityPublicFloat
24100000
CY2020 dei Entity File Number
EntityFileNumber
001-37746
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-1567056
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
2401 4th Avenue
CY2020 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1050
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98121
CY2020 dei City Area Code
CityAreaCode
206
CY2020 dei Local Phone Number
LocalPhoneNumber
838-0500
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q4 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
2369000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2228000
CY2019Q4 apvo Assets Held For Sale Current
AssetsHeldForSaleCurrent
16309000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Assets
Assets
53408000
CY2019Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
6428000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2870000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
944000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
38239000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
757000
CY2019 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-14.76
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2917035
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-17750000
CY2019 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.90
CY2020 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-9.12
CY2020 us-gaap Profit Loss
ProfitLoss
-17750000
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
3.88
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-42383000
CY2019 us-gaap Profit Loss
ProfitLoss
-40448000
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
13173000
CY2019 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
2616000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
1255000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-40448000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
1598000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1406000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2235000
CY2019 apvo Non Cash Interest Expense And Other
NonCashInterestExpenseAndOther
673000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
153000
CY2020 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
28120000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
28032000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4097000
CY2020 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
24731000
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
22104000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17852000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24763000
CY2019Q4 us-gaap Liabilities
Liabilities
41566000
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11842000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53408000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3234231
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3234231
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3390919
CY2020Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
14338000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4309000
CY2019 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
-1634000
CY2020 us-gaap Adjustment For Amortization
AdjustmentForAmortization
100000
CY2019 us-gaap Adjustment For Amortization
AdjustmentForAmortization
800000
CY2020 apvo Depreciation Or Capital Expenditures
DepreciationOrCapitalExpenditures
0
CY2019 apvo Depreciation Or Capital Expenditures
DepreciationOrCapitalExpenditures
0
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
35378000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19946000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-30923000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30923000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12448000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4410909
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2815000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2722000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3747000
CY2019Q4 apvo Assets Held For Sale Non Current
AssetsHeldForSaleNonCurrent
7465000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
746000
CY2020Q4 us-gaap Assets
Assets
53547000
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
5583000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2757000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5000000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
19863000
CY2019Q4 apvo Liabilities Held For Sale Current
LiabilitiesHeldForSaleCurrent
8134000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1199000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14539000
CY2020Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
20054000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2360000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3327000
CY2020Q4 us-gaap Liabilities
Liabilities
36953000
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
46000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
45000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
202154000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
179653000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-185606000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-167856000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
16594000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53547000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4410909
CY2020 apvo Other Expense From Continuing Operations
OtherExpenseFromContinuingOperations
1325000
CY2019 apvo Other Expense From Continuing Operations
OtherExpenseFromContinuingOperations
2102000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2104000
CY2019 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-43064000
CY2020 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
14338000
CY2019 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
4250000
CY2020 apvo Non Cash Interest Expense And Other
NonCashInterestExpenseAndOther
411000
CY2020 apvo Increase Decrease In Royalties Receivable
IncreaseDecreaseInRoyaltiesReceivable
2369000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1112000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2212000
CY2020 apvo Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
1025000
CY2019 apvo Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
945000
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-702000
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2697000
CY2020 apvo Increase Decrease In Long Term Operating Lease Liability
IncreaseDecreaseInLongTermOperatingLeaseLiability
967000
CY2019 apvo Increase Decrease In Long Term Operating Lease Liability
IncreaseDecreaseInLongTermOperatingLeaseLiability
1039000
CY2020 apvo Increase Decrease In Assets And Liabilities Held For Sale
IncreaseDecreaseInAssetsAndLiabilitiesHeldForSale
-1719000
CY2019 apvo Increase Decrease In Assets And Liabilities Held For Sale
IncreaseDecreaseInAssetsAndLiabilitiesHeldForSale
1612000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29318000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88000
CY2019 apvo Proceeds From Divestiture Of Businesses1
ProceedsFromDivestitureOfBusinesses1
4250000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
34118000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
28221000
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
306000
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
3869000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1042000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1023000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
3626000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
3044000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2345000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1718000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
2241000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
1447000
CY2020Q4 apvo Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
772000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
44923000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
44291000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-43064000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43064000
CY2020Q2 apvo Number Of Holders
NumberOfHolders
52
CY2020Q2 apvo Employee Stock Ownership Plan Esop Percentage Of Allocated Shares
EmployeeStockOwnershipPlanESOPPercentageOfAllocatedShares
0.96
CY2020Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
200016
CY2020Q3 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
84900
CY2020 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-30923000
CY2019 apvo Proceeds From Long Term Debt Net Of Issuance Costs And Modification Fees
ProceedsFromLongTermDebtNetOfIssuanceCostsAndModificationFees
-137000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23000
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
21235000
CY2019 apvo Proceeds From Issuance Of Common Stock Warrants And Pre Funded Warrants Net
ProceedsFromIssuanceOfCommonStockWarrantsAndPreFundedWarrantsNet
20344000
CY2020 apvo Payment Of Tax Liability For Vested Equity Awards
PaymentOfTaxLiabilityForVestedEquityAwards
11000
CY2019 apvo Payment Of Tax Liability For Vested Equity Awards
PaymentOfTaxLiabilityForVestedEquityAwards
58000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23874000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20149000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22588000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-18137000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19946000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
38083000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
42534000
CY2019 apvo Stock Issued During Period Value Common Stock Pre Funded Warrants And Warrants Net
StockIssuedDuringPeriodValueCommonStockPreFundedWarrantsAndWarrantsNet
20344000
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-58000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1598000
CY2020 apvo Proceeds From Exercise Of Stock Options Value
ProceedsFromExerciseOfStockOptionsValue
-23000
CY2020 apvo Proceeds From Exercise Of Warrants Value
ProceedsFromExerciseOfWarrantsValue
-21235000
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent liabilities in the consolidated financial statements and accompanying notes. Estimates are used for, but not limited to, useful lives of equipment, clinical trial accruals, income taxes, commitments and contingencies, stock-based compensation, and collectability of receivables. Given the global economic climate and additional or unforeseen effects from the COVID-19 pandemic, these estimates are becoming more challenging, and actual results could differ materially from those estimates.</p>
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject Aptevo to concentrations of credit risk consist primarily of cash and cash equivalents, certain investments and royalties receivable. Aptevo places its cash and cash equivalents with high quality financial institutions and may maintain cash balances in excess of insured limits. Management believes that the financial risks associated with its cash and cash equivalents are minimal.</p>
CY2020Q4 us-gaap Cash
Cash
4601000
CY2019Q4 us-gaap Cash
Cash
4954000
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
7494000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42534000
CY2020Q4 apvo Number Of Technology Platforms
NumberOfTechnologyPlatforms
2
CY2020Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
we effected a 1-for-14 reverse stock split (the “Reverse Split”) of our common stock pursuant to which every 14 shares of our common stock issued and outstanding as of March 26, 2020 were automatically combined into one issued and outstanding share of common stock. No fractional shares were issued as a result of the reverse stock split.
CY2020Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.071
CY2020 apvo Fractional Shares Reverse Stock Split
FractionalSharesReverseStockSplit
0
CY2020 apvo Royalty Rate
RoyaltyRate
0.025
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2019Q3 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
4250000
CY2020Q1 apvo Cash Payment Received
CashPaymentReceived
29250000
CY2020Q1 us-gaap Escrow Deposit
EscrowDeposit
750000
CY2020Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
30000000
CY2020Q1 apvo Net Carrying Value Of Assets Transferred
NetCarryingValueOfAssetsTransferred
13376000
CY2020Q1 apvo Transaction Cost
TransactionCost
1880000
CY2020Q1 apvo Minimum Transition Services Agreement Tsa Fund
MinimumTransitionServicesAgreementTSAFund
406000
CY2019Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net
DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
7022000
CY2019Q4 us-gaap Disposal Group Including Discontinued Operation Inventory Current
DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
6140000
CY2019Q4 us-gaap Disposal Group Including Discontinued Operation Prepaid And Other Assets Current
DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
3147000
CY2019Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
16309000
CY2019Q4 us-gaap Disposal Group Including Discontinued Operation Intangible Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
4420000
CY2019Q4 apvo Disposal Group Including Discontinued Operation Vat Receivable And Deposit
DisposalGroupIncludingDiscontinuedOperationVATReceivableAndDeposit
3045000
CY2019Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
23774000
CY2019Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities Current
DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent
5043000
CY2019Q4 apvo Disposal Group Including Discontinued Operation Royalties Payable
DisposalGroupIncludingDiscontinuedOperationRoyaltiesPayable
2018000
CY2019Q4 apvo Disposal Group Including Discontinued Operation Accrued Payroll Payable
DisposalGroupIncludingDiscontinuedOperationAccruedPayrollPayable
654000
CY2019Q4 us-gaap Disposal Group Including Discontinued Operation Other Current Liabilities
DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities
419000
CY2019Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
8134000
CY2020 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
-1582000
CY2020 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
14338000
CY2019 apvo Milestone Payment
MilestonePayment
4250000
CY2020 apvo Disposal Group Including Discontinued Operations Deferred Revenue
DisposalGroupIncludingDiscontinuedOperationsDeferredRevenue
417000
CY2020 apvo Investing Non Cash Items
InvestingNonCashItems
0
CY2019 apvo Investing Non Cash Items
InvestingNonCashItems
0
CY2020Q1 apvo Other Noncash Operating Activities Discontinued Operations
OtherNoncashOperatingActivitiesDiscontinuedOperations
400000
CY2020 apvo Other Noncash Operating Activities Discontinued Operations
OtherNoncashOperatingActivitiesDiscontinuedOperations
200000
CY2019 apvo Reduction In Research And Development Expense
ReductionInResearchAndDevelopmentExpense
1400000
CY2019Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
12500000
CY2020 apvo Cash Equivalents Maturity Period
CashEquivalentsMaturityPeriod
P90D
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13958000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13870000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11143000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1399000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4080000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
752000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
1714000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1387000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1294000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9924000
CY2020 us-gaap Depreciation
Depreciation
1200000
CY2019 us-gaap Depreciation
Depreciation
1400000
CY2020Q4 apvo Unamortized Loan Initiation Fees
UnamortizedLoanInitiationFees
100000
CY2020Q4 apvo Loss On Debt Extinguishment
LossOnDebtExtinguishment
2100000
CY2020Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
25000000
CY2020Q4 us-gaap Business Acquisition Description Of Acquired Entity
BusinessAcquisitionDescriptionOfAcquiredEntity
This acquisition of voting stock triggered a change in control, resulting in an Event of Default under Section 10.1(a)(ii) of the Credit Agreement. On November 10, 2020, the Company obtained a waiver from MidCap Financial pursuant to which, among other things, MidCap Financial waived the event of default arising from the acquisition of voting stock by Tang and MidCap Financial and the Company agreed that an immediate event of default under the Credit Agreement will be deemed to have occurred in the event that (a) a majority of the seats on the Company’s board of directors are occupied by persons who were neither (i) nominated by the Company’s board of directors nor (ii) appointed by the directors so nominated, and (b) Tang has appointed the majority of the Company’s board of directors. No other events of default have occurred with respect to the Company’s credit agreement.
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
6945000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
16935000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
4340000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
28220000
CY2020 apvo Operating Lease Property Number Of Lab Equipment
OperatingLeasePropertyNumberOfLabEquipment
1
CY2020 apvo Operating Lease Property Number Of Copiers
OperatingLeasePropertyNumberOfCopiers
4
CY2020 apvo Finance Lease Number Of Equipment
FinanceLeaseNumberOfEquipment
1
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
1580000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
1526000
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
6000
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
6000
CY2020 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
2000
CY2020 us-gaap Lease Cost
LeaseCost
1587000
CY2019 us-gaap Lease Cost
LeaseCost
1534000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2722000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3747000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
1480000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3328000
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y3M18D
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1452
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1455
CY2020 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
a reverse split of Aptevo’s common stock at a ratio ranging from 1-for-2 to 1-for-20, inclusive, with the effectiveness of one of such amendments and the abandonment of the other amendments, or the abandonment of all amendments, to be determined by the Board in its sole discretion following the Special Meeting. The specific 1-for-14 reverse split ratio was subsequently approved by the Board on March 23, 2020. On March 26, 2020, the Company filed a Certificate of Amendment of Amended and Restated Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-14 reverse stock split of the Company’s outstanding common stock.
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
18.20
CY2020 apvo Number Of Common Stock Shares To Be Issued Upon Exercise Of Warrants
NumberOfCommonStockSharesToBeIssuedUponExerciseOfWarrants
1166735000000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1255000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1598000
CY2019 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
400000
CY2020Q2 us-gaap Conversion Of Stock Description
ConversionOfStockDescription
On June 29, 2020, Aptevo commenced a voluntary employee and directors stock option exchange program (the Exchange Program) to permit the Company’s eligible employees, directors and certain consultants to exchange some or all of their eligible outstanding options (Original Options) to purchase the Company’s common stock with an exercise price greater than or equal to $21.00 per share,
CY2020Q2 apvo Exercise Price Of Options Exercised
ExercisePriceOfOptionsExercised
8.56
CY2020Q3 apvo Share Based Goods And Nonemployee Services Transaction Remaining Unamortized Compensation Cost
ShareBasedGoodsAndNonemployeeServicesTransactionRemainingUnamortizedCompensationCost
40000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
325904
CY2019Q1 apvo Pre Funded Warrants And Rights Outstanding Term
PreFundedWarrantsAndRightsOutstandingTerm
P10Y
CY2019Q1 apvo Prefunded Warrant Expiration Date
PrefundedWarrantExpirationDate
2029-03-11
CY2020Q4 apvo Number Of Common Stock Shares To Be Issued Upon Exercise Of Warrants
NumberOfCommonStockSharesToBeIssuedUponExerciseOfWarrants
1166735000000
CY2020Q4 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
21200000
CY2020 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2020 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
300000
CY2019Q4 apvo Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
992000
CY2020Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
473000
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
453000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
40767000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
39895000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
632000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
872000
CY2020Q4 apvo Deferred Tax Liability Right Of Use Assets
DeferredTaxLiabilityRightOfUseAssets
632000
CY2019Q4 apvo Deferred Tax Liability Right Of Use Assets
DeferredTaxLiabilityRightOfUseAssets
874000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
632000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
874000
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2000
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
121600000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.019
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.018
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.241
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.237
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.035
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.016
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.011
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.007
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.012
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000

Files In Submission

Name View Source Status
0001564590-21-016875-index-headers.html Edgar Link pending
0001564590-21-016875-index.html Edgar Link pending
0001564590-21-016875.txt Edgar Link pending
0001564590-21-016875-xbrl.zip Edgar Link pending
apvo-10k_20201231.htm Edgar Link pending
apvo-20201231.xml Edgar Link completed
apvo-20201231.xsd Edgar Link pending
apvo-20201231_cal.xml Edgar Link unprocessable
apvo-20201231_def.xml Edgar Link unprocessable
apvo-20201231_lab.xml Edgar Link unprocessable
apvo-20201231_pre.xml Edgar Link unprocessable
apvo-ex211_10.htm Edgar Link pending
apvo-ex231_9.htm Edgar Link pending
apvo-ex232_11.htm Edgar Link pending
apvo-ex311_7.htm Edgar Link pending
apvo-ex312_8.htm Edgar Link pending
apvo-ex321_12.htm Edgar Link pending
apvo-ex322_6.htm Edgar Link pending
apvo-ex45_509.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gcbqmfnojuj2000001.jpg Edgar Link pending
gcbqmfnojuj2000002.jpg Edgar Link pending
gcbqmfnojuj2000003.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending